RecruitingNCT03376165

Post-Operative Myocardial Incident & Atrial Fibrillation

Longitudinal Study of Patients Undergoing Cardiac Surgery or Implantation of a Percutaneous Valve Prosthesis

Sponsor

University Hospital, Lille

Enrollment

1,500 participants

Start Date

Jan 30, 2018

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease Valve Heart Disease

Summary

To explore predictors of major cardio-vascular events after cardiac surgery and trans-catheter valve implantation with a specific interest in studying mechanisms linking pre-operative leukocyte, fat and myocardial phenotypes with post-intervention outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is collecting information about patients undergoing heart surgery or a minimally invasive heart valve procedure to better understand the rates of heart complications — specifically heart muscle injury and new irregular heartbeat (atrial fibrillation) — that occur after these procedures. **You may be eligible if...** - You are scheduled for heart surgery such as coronary artery bypass graft surgery, heart valve repair or replacement, or a minimally invasive valve procedure (transcatheter valve implantation) **You may NOT be eligible if...** - You are pregnant - Your surgery is being performed urgently or as an emergency - You are not able to consent to the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Hôpital Cardiologie, CHU

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03376165

Related Trials

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

NCT067368998 locations

Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

NCT067102101 location

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

NCT0542737043 locations

Scaffold in Emilia Romagna and in the MAGIC Network

NCT0332796117 locations

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

NCT034439997 locations